Karolina Rask
Board of Directors
Pharmaceuticals
merozyne
Denmark
Biography
Karolina obtained her MSc degree in biomedical chemistry for Kalmar University in 2000. Her early career started off as a molecular biologist working at Rockefeller University in New York City where she did her master thesis. Currently she holds a position as Director Clinical Development at AstraZeneca in Göteborg Sweden. Her career has for the past 12 years been focused within clinical development in a number of positions in pharma, biotech and the CRO industry (in Novo Nordisk, Genmab, Mitsubishi Tanabe pharma etc.), having a global career spread between the US, UK, Sweden and Denmark. For about three years she ran as CEO a virtual biotech company called Thrombologic where Novo Seeds was an investor where she worked with re-positioning known compounds towards an orphan disease and severe sepsis.
Research Interest
Pharmaceuticals
